Possible Connection between Autism, Narcolepsy and Multiple Sclerosis

Autism

Volumn 2, Issue 4, 1998, Pages 425-427

  Cohen, Brett I ^a  

^a ED Laboratories   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84990361040     PISSN: 13623613     EISSN: None     Source Type: Journal    
DOI: 10.1177/1362361398024008     Document Type: Article

References (17)

1. BATCHELOR, J.R., COMPSTON, A. & MCDONALD, W.I. (1978) ‘Genetic Markers in Multiple Sclerosis’, British Medical Bulletin 34: 279-284.
2. BONDUELLE, M. & DEGROS, C. (1976) ‘Symptomatic Narcolepsies: A Critical Study’, in c. GUILLEMINAULT, W.C. DEMENT & P. PASSOUANT (eds) Narcolepsy, pp. 313-332. New York: Spectrum Publications.
3. CARLANDER, B., ELIAOU, J.F. & BILLIARD, M. (1993) ‘Autoimmune Hypothesis in Narcolepsy’, Neurophysiology Clinical 23: 15-22.
4. COOK, E.H., CHARAK, D.A., ARIDA, J., SPOHN, J.A., ROIZEN, N.J.M. & LEVENTHAL, B. L. (1994) ‘Depressive and Obsessive-Compulsive Symptoms in Hyperserotonemic Parents of Children with Autistic Disorders’, Psychiatry Research 52: 25-33.
5. DANIELS, W.W., WARREN, R.P., ODELL, J.D., MACIULIS, A., BURGER, R.A., WARREN, W. L. & TORRES, A. R. (1995) ‘Increased Frequency of the Extended or Ancestral Haplotype B44-SC30-DR4 in Autism’, Neuropsychobiology 32: 120-123.
6. DEMENT, W., ZARCONE, V., VARNER, V. & RAINE, C.S. (1972) ‘The Prevalence of Narcolepsy’, Sleep Research 1: 148-148.
7. DE TRIBOLET, N., HUMOU, M.F., MACH, J.P., CARREL, S. & SCHREYER, M. (1984) ‘Class II HLA Antigen Distribution in the Brain,’ Journal of Neurology Neurosurgery Psyhiatry 47: 417-418.
8. FOLSTEIN, S. & RUTTER, M. (1977) ‘Infantile Autism: A Genetic Study of 21 Twin Pairs’, Journal of Children Psychiatry and Allied Discipline 18: 297-321.
9. GELLER, E., RITVO, E.R., FREEMAN, B.J. & YUWILER, A. (1982) ‘Preliminary Observations on the Effect of Fenfluramine on Blood Serotonin and Symptoms in Three Autistic Boys’, New England Journal of Medicine 307: 165-169.
10. HANLEY, H. G., STAHL, S. M. & FREEDMAN, D. X. (1977) ‘Hyperserotonemia and Amine Metabolites in Autistic and Retarded Children’, Archives of General Psychiatry 34: 521-531.
11. KUPERMAN, S., BEEGHLY, J.H.L., BURNS, T.I. & TSAI, L.Y. (1985) ‘Serotonin Relationships of Autistic Probands and their First-Degree Relatives’, Journal of American Academic Psychiatry 24: 186-190.
12. LANGDOM, N., WELSH, K.I., VAN DAM, M., VAUGHAM, R.W. & PARKS, D. (1984) ‘Genetic Markers in Narcolepsy’, Lancet 1984: 1178-1180.
13. RITVO, E.R., YUWILER, A., GELLER, E., ORNITZ, E.M., SAEGER, K. & PLOTKINS, S. (1970) ‘Increased Blood Serotonin and Platelets in Early Infantile Autism’, Archives of General Psychiatry 23: 566-572.
14. SCHRADER, H., GOTLIBSEN, O.B. & SKOMEDAL, G.N. (1980) ‘Multiple Sclerosis and Narcolepsy-Cataplexy in a Monozygotic Twin’, Neurology 30: 105-108.
15. WARREN, R.P., ODELL, J.D., WARREN, W.L., BURGER, R.A., MACIULIUS, A., DANIELS, W.W. & TORRES, A.R. (1996a) ‘Strong Association of the Third Hypervariable Region of HLA-DR Beta 1 with Autism’, Joumnal of Neuroimmunology 67: 97-102.
16. WARREN, R.P., SINGH, V.K., AVERETT, R.E., ODELL, J.D., MACIULIS, A., BURGER, R.A., DANIELS, W.W. & WARREN, W.L. (1996b) ‘Immunogenetic Studies in Autism and Related Disorders’, Molecular Chemical Neuropathlogy 28: 77-81.
17. WELSH, KI. (1984) ‘Genetic Markers in Neurological Diseases’, in P. o. BEHAN & F. SPEAFICO (eds) Neuroimmunology, pp. 469-473. New York: Raven Press.